DERM (Journey Medical) Other Current Assets: $3.46 Mil (As of Mar. 2026)


DERM Journey Medical Corp DERM
63 GF Score
Price $7.09
GF Value $4.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Journey Medical Other Current Assets?

Journey Medical DERM +0.85% 63 Other Current Assets is $3.46 Mil as of Mar. 2026. GuruFocus rates DERM with a GF Score™ of 63/100 and a GF Value™ of $4.19 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Journey Medical's other current assets for the quarter that ended in Mar. 2026 was $3.46 Mil.

Journey Medical's quarterly other current assets increased from Sep. 2025 ($1.64 Mil) to Dec. 2025 ($3.38 Mil) and increased from Dec. 2025 ($3.38 Mil) to Mar. 2026 ($3.46Mil).

Journey Medical's annual other current assets declined from Dec. 2023 ($3.59 Mil) to Dec. 2024 ($3.21 Mil) increased from Dec. 2024 ($3.21 Mil) to Dec. 2025 ($3.38 Mil).


Journey Medical Other Current Assets Related Terms


Journey Medical Other Current Assets Historical Data

* Premium members only.

The historical data trend for Journey Medical's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Journey Medical Other Current Assets Chart

Journey Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial 2.44 3.31 3.59 3.21 3.38

Journey Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.40 2.48 1.64 3.38 3.46
DERM
63GF Score
Journey Medical Corp DERM
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Journey Medical Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of $3.46 Mil mean?
Journey Medical (DERM) has a Other Current Assets of $3.46 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Journey Medical.
Is Journey Medical's Other Current Assets too high?
Journey Medical's current Other Current Assets is $3.46 Mil. Overall, Journey Medical has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Journey Medical's Other Current Assets compare to LFCR and ANIK?
Journey Medical's Other Current Assets of $3.46 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Journey Medical. Journey Medical's current Other Current Assets is $3.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Journey Medical stock overvalued right now?
Based on GuruFocus' analysis, Journey Medical (DERM) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.19, compared to a current price of $7.09 — trading 69.1% above its estimated fair value. The current Other Current Assets is $3.46 Mil. Journey Medical's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Journey Medical (DERM), the current Other Current Assets is $3.46 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Journey Medical (DERM) Overvalued in 2026?

Based on GuruFocus' analysis, Journey Medical stock appears to be overvalued. The current stock price of $7.09 is trading 69.1% above its estimated GF Value™ of $4.19. GuruFocus considers Journey Medical to be Significantly Overvalued.

Key valuation signals for DERM:

  • Other Current Assets: $3.46 Mil
  • GF Value™: $4.19 vs. price of $7.09 (69.1% above fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the DERM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Journey Medical Business Description

Address 9237 E Via de Ventura Boulevard, Suite 105, Scottsdale, AZ, USA, 85258
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
63GF Score

Get the complete analysis for DERM

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.09
Price
$4.19
GF Value